These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37977816)

  • 1. Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice.
    McClintic WT; Chandler ZD; Karchalla LM; Ondeck CA; O'Brien SW; Campbell CJ; Jacobson AR; McNutt PM
    J Pharmacol Exp Ther; 2024 Jan; 388(2):637-646. PubMed ID: 37977816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
    Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM
    Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic treatment of botulism with a clinically approved small molecule.
    Vazquez-Cintron E; Machamer J; Ondeck C; Pagarigan K; Winner B; Bodner P; Kelly K; Pennington MR; McNutt P
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
    Bradford AB; Machamer JB; Russo TM; McNutt PM
    Toxicol Appl Pharmacol; 2018 Feb; 341():77-86. PubMed ID: 29366638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.
    Beske PH; Hoffman KM; Machamer JB; Eisen MR; McNutt PM
    Sci Rep; 2017 Nov; 7(1):15862. PubMed ID: 29158500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL
    Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F.
    Siegel LS; Johnson-Winegar AD; Sellin LC
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.
    Mayorov AV; Willis B; Di Mola A; Adler D; Borgia J; Jackson O; Wang J; Luo Y; Tang L; Knapp RJ; Natarajan C; Goodnough MC; Zilberberg N; Simpson LL; Janda KD
    ACS Chem Biol; 2010 Dec; 5(12):1183-91. PubMed ID: 20936877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS; Price JI
    Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations.
    Adler M; Deshpande SS; Apland JP; Murray B; Borrell A
    Neurochem Int; 2012 Nov; 61(6):866-73. PubMed ID: 22841859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.
    Zakhari JS; Kinoyama I; Hixon MS; Di Mola A; Globisch D; Janda KD
    Bioorg Med Chem; 2011 Nov; 19(21):6203-9. PubMed ID: 21975066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
    Adler M; Capacio B; Deshpande SS
    Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
    Adler M; Macdonald DA; Sellin LC; Parker GW
    Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations.
    Adler M; Scovill J; Parker G; Lebeda FJ; Piotrowski J; Deshpande SS
    Toxicon; 1995 Apr; 33(4):527-37. PubMed ID: 7570638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Diaminopyridine reverses respiratory paralysis induced by a presynaptically active snake venom and its major neurotoxin.
    Watt G; Smith CD; Kaewsupo A; Davis TM
    Trans R Soc Trop Med Hyg; 1994; 88(2):243-6. PubMed ID: 8036689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model.
    Torgeman A; Schwartz A; Diamant E; Baruchi T; Dor E; Ben David A; Pass A; Barnea A; Tal A; Rosner A; Rosen O; Zichel R
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic botulism cases after gastric and axillary application of botulinum toxin and review of literature.
    Eser F; Hasanoğlu İ; Kayaaslan B; Kaya Kalem A; Bilen Ş; Orhan G; Güner R
    J Infect Dev Ctries; 2024 Mar; 18(3):480-487. PubMed ID: 38635607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to Counteract Botulinum Neurotoxin A: Nature's Deadliest Biomolecule.
    Lin L; Olson ME; Eubanks LM; Janda KD
    Acc Chem Res; 2019 Aug; 52(8):2322-2331. PubMed ID: 31322847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism.
    Torgeman A; Diamant E; Dor E; Schwartz A; Baruchi T; Ben David A; Zichel R
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?
    Karcioglu O; Akman C; Atnis I
    Curr Pharm Des; 2024; 30(8):578-588. PubMed ID: 38409723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.